Hans Klingemann
Company: ImmunityBio, Inc.
Job title: Vice President - Research & Development
Seminars:
Engineered NK-92 (aNKTM) Cells – Preclinical & Clinical Results 2:00 pm
Download the full event guide to find out more on session detailsRead more
day: Day One Track B - Middle